The ABC of non-inferiority margin setting from indirect comparisons

Pharmaceutical Statistics

Volumn 10, Issue 5, 2011, Pages 448-453

  Julious, Steven A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

clinical trials; indirect comparisons; non inferiority; placebo creep

Indexed keywords

PAROXETINE; PLACEBO;

ARTICLE; ASSAY; BAYESIAN LEARNING; CLINICAL TRIAL (TOPIC); EFFECT SIZE; HUMAN; POPULATION RESEARCH; PROBABILITY; SENSITIVITY ANALYSIS; SYSTEMATIC ERROR;

BAYES THEOREM; BIAS (EPIDEMIOLOGY); CONFIDENCE INTERVALS; CONTROL GROUPS; HUMANS; MODELS, STATISTICAL; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 80053561105     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.517     Document Type: Article

References (13)

1. CPMP. Points to consider on switching between superiority and non-inferiority. (CPMP/EWP/482/99),17 July 2000.
2. Julious SA,. Sample Sizes for Clinical Trials, Chapman and Hall: London, 2009.
3. FDA guidance for industry, non-inferiority clinical trials (draft),March 2010.
4. Julious SA, Wang SJ,. Issues with indirect comparisons in clinical trials particularly with respect to non-inferiority trials. DIJ 2008; 42 (6): 625-633.
5. Julious SA,. Tutorial in Biostatistics: Sample sizes for clinical trials with normal data. Statistics in Medicine 2004; 23: 1921-1986. (Pubitemid 38787092)
6. Hasselblad V, Kong DF,. Statistical methods for comparison to placebo in active-control trials. Drug Information Journal 2001; 25: 435-449. (Pubitemid 32524896)
7. Lim E, Ali Z, Ali A, Routledge T, Edmonds L, Altman DG, Large S,. Indirect comparison meta-analysis of aspirin therapy after coronary surgery. British Medical Journal 2003; 327: 1309-1313.
8. Wang SJ, Hung HMJ, Tsong Y,. Utility and pitfalls of some statistical methods in active controlled trials. Controlled Clinical Trials 2002; 23: 15-28. (Pubitemid 34164355)
9. Song F, Altman DG, Glenny AM, Deeks JJ,. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. British Medical Journal 2003; 326: 472-5. (Pubitemid 36269627)
10. D'Agostino RB, Massaro J, Sullivan LM,. Non-inferiority trials: design concepts and issues-the encounters of academic consultants in statistics. Statistics in Medicine 2003; 22: 169-186. (Pubitemid 36163579)
11. Wang SJ, Hung HMJ, Tsong Y,. Non-inferiority analysis in active controlled clinical trials, In Encyclopedia of Biopharmaceutical Statistics, (3rd edn), Vols. 1 and 2, Marcel Dekker, New York, NY, 2010. Chapter 146.
12. Snapinn SM,. Alternatives for discounting in the analysis of non-inferiority trials. Journal of Biopharmaceutical Statistics 2004; 14: 263-273. (Pubitemid 38715780)
13. Julious SA, Owen R,. Sample size calculations for non-inferiority studies with binary outcomes. Statistical Methods in Medical Research 2011. DOI: 10.1177/0962280210378945.